34 Healthcare Stocks Moving In Wednesday's Pre-Market Session

Gainers

  • OrganiGram Holdings, Inc. OGI shares increased by 26.9% to $2.74 during Wednesday's pre-market session. According to the most recent rating by Raymond James, on January 09, the current rating is at Market Perform.
  • Rockwell Medical, Inc. RMTI stock rose 23.3% to $2.86. The most recent rating by Piper Jaffray, on November 12, is at Overweight, with a price target of $6.00.
  • Oncolytics Biotech, Inc. ONCY stock increased by 16.7% to $3.35.
  • Clovis Oncology, Inc. CLVS stock moved upwards by 15.6% to $10.29. The most recent rating by Evercore ISI Group, on November 19, is at In-Line, with a price target of $8.00.
  • Momenta Pharmaceuticals, Inc. MNTA stock moved upwards by 14.8% to $29.12. The most recent rating by JP Morgan, on January 15, is at Overweight, with a price target of $30.00.
  • Durect, Inc. DRRX stock increased by 13.4% to $2.79. The most recent rating by Cantor Fitzgerald, on November 18, is at Overweight, with a price target of $5.00.
  • Neovasc, Inc. NVCN shares increased by 13.3% to $3.50. The most recent rating by H.C. Wainwright, on October 24, is at Buy, with a price target of $9.00.
  • Beyond Air, Inc. XAIR shares surged 8.8% to $6.30. The most recent rating by Oppenheimer, on October 22, is at Outperform, with a price target of $9.00.
  • TRACON Pharmaceuticals, Inc. TCON shares increased by 7.1% to $3.00. The most recent rating by H.C. Wainwright, on December 23, is at Buy, with a price target of $18.00.
  • Tilray, Inc. TLRY shares surged 5.4% to $22.36. The most recent rating by B of A Securities, on January 13, is at Neutral, with a price target of $18.00.
  • ASLAN Pharmaceuticals, Inc. ASLN shares increased by 5.2% to $2.61. The most recent rating by H.C. Wainwright, on December 10, is at Buy, with a price target of $5.00.
  • OpGen, Inc. OPGN stock surged 4.3% to $1.69.
  • Titan Pharmaceuticals, Inc. TTNP stock rose 4.2% to $0.28. The most recent rating by Maxim Group, on October 23, is at Buy, with a price target of $1.00.
  • HEXO, Inc. HEXO shares surged 3.8% to $1.65.
  • Aurora Cannabis, Inc. ACB shares moved upwards by 3.6% to $1.85. The most recent rating by Piper Sandler, on January 10, is at Underweight, with a price target of $1.00.
  • Sorrento Therapeutics, Inc. SRNE stock moved upwards by 3.2% to $4.24.
  • Aphria, Inc. APHA shares moved upwards by 3.0% to $5.13. According to the most recent rating by B of A Securities, on January 13, the current rating is at Neutral.
  • ContraFect, Inc. CFRX stock rose 2.5% to $1.26.
  • Microbot Medical, Inc. MBOT stock surged 2.2% to $11.85. The most recent rating by H.C. Wainwright, on January 13, is at Buy, with a price target of $26.00.
  • CannTrust Holdings, Inc. CTST stock rose 1.8% to $1.13.
  • Acorda Therapeutics, Inc. ACOR shares rose 1.7% to $2.38. According to the most recent rating by JP Morgan, on October 24, the current rating is at Underweight.
  • Canopy Growth, Inc. CGC stock surged 1.7% to $24.25. According to the most recent rating by Bank of America, on November 20, the current rating is at Buy.
  • Novo Nordisk, Inc. NVO stock rose 1.7% to $60.61. The most recent rating by Ladenburg Thalmann, on January 06, is at Buy, with a price target of $15.00.

 

Losers

  • Accelerate Diagnostics, Inc. AXDX shares plummeted 15.8% to $15.25 during Wednesday's pre-market session.
  • Nektar Therapeutics, Inc. NKTR stock plummeted 14.7% to $23.84. The most recent rating by JP Morgan, on November 13, is at Neutral, with a price target of $28.00.
  • Midatech Pharma, Inc. MTP stock decreased by 10.0% to $0.90.
  • Adaptimmune Therapeutics, Inc. ADAP shares plummeted 5.9% to $3.80.
  • Acasti Pharma, Inc. ACST shares fell 4.3% to $0.90. The most recent rating by B. Riley FBR, on January 13, is at Neutral, with a price target of $2.00.
  • Genetic Technologies, Inc. GENE stock decreased by 3.9% to $4.23.
  • La Jolla Pharmaceutical, Inc. LJPC shares plummeted 3.6% to $8.52. According to the most recent rating by H.C. Wainwright, on November 26, the current rating is at Neutral.
  • Cyclerion Therapeutics, Inc. CYCN shares fell 2.7% to $3.60.
  • Cassava Sciences, Inc. SAVA stock decreased by 2.1% to $7.36. The most recent rating by H.C. Wainwright, on December 06, is at Buy, with a price target of $6.00.
  • Dare Bioscience, Inc. DARE stock plummeted 1.5% to $1.35.
  • UnitedHealth Group, Inc. UNH stock plummeted 1.2% to $284.50. The most recent rating by Credit Suisse, on January 08, is at Outperform, with a price target of $330.00.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsMovers & ShakersPre-Market OutlookMarketsMoversTrading IdeasGeneralBiotechnologyHealth CareHealthcare Stocks Pre-Market MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!